Skip to main content
logo
Accretion Pharmaceuticals Limited (NSE:ACCPL)
India flag India · Delayed Price · Currency is INR
202.30
-5.70 (-2.74%)
At close: Aug 21, 2026

Accretion Pharmaceuticals Ratios and Metrics

Millions INR. Fiscal year is Apr - Mar.

Total Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Market Capitalization
2,249706----
Market Cap Growth
244.05%-----
Enterprise Value
2,332783----
Last Close Price
202.3063.55----

Price Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PE Ratio
22.407.31----
PS Ratio
2.510.79----
PB Ratio
4.111.29----
P/TBV Ratio
4.111.29----

EV Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
EV/Sales Ratio
2.600.87----
EV/EBITDA Ratio
15.485.20----
EV/EBIT Ratio
16.845.66----

Financial Efficiency

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Debt / Equity Ratio
0.230.230.922.452.202.47
Debt / EBITDA Ratio
0.820.821.185.223.963.94
Debt / FCF Ratio
-----4.02
Net Debt / Equity Ratio
0.150.150.922.442.192.35
Net Debt / EBITDA Ratio
0.550.551.185.193.943.75
Net Debt / FCF Ratio
-0.36-0.36-6.30-0.79-9.843.82
Asset Turnover
1.541.541.710.561.54-
Inventory Turnover
2.682.682.280.853.27-
Quick Ratio
1.411.410.540.460.420.38
Current Ratio
2.902.901.441.461.051.01
Return on Equity (ROE)
27.62%27.62%65.39%31.98%3.00%-
Return on Assets (ROA)
14.85%14.85%20.67%6.14%3.96%-
Return on Invested Capital (ROIC)
16.24%22.16%32.12%11.33%8.06%8.26%
Return on Capital Employed (ROCE)
24.80%24.80%66.80%19.00%18.00%18.60%

Yields

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Earnings Yield
4.30%13.69%----
FCF Yield
-10.26%-32.66%----
Buyback Yield / Dilution
-33.55%-33.55%-5.47%---